Blueberries Medical (BBM.CN) Stock Price

Blueberries Medical Price

CSE·CLOSED
0.01
​
Market closed

Over the last 6 years Blueberries Medical grew revenue by 101.7% annually, reaching 312,285.00 CAD. For Blueberries Medical, the net margin of -533.4% is up versus -3,709.6% a few years ago.

Blueberries Medical stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Blueberries Medical business model & stock analysis

Blueberries Medical Corp, listed under ticker BBM.CN with ISIN CA09609Y1016, is a Canadian company headquartered in Toronto, Ontario. The company went public via an IPO on April 9, 2014. Blueberries Medical Corp operates within the Health Care sector, specifically in the Pharmaceuticals industry. The company is engaged in the production and distribution of both psychoactive and non-psychoactive cannabis by-products. Its operations include the growth, cultivation, and development of medicinal cannabis and related products, with a presence in Colombia. The firm focuses on processing and supplying medicinal-grade cannabis oil extracts, medical flowers, and related products. Blueberries Medical Corp is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The company's subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs), and SATIN S.A.S. (SATIN). Blueberries SAS, a subsidiary, is a licensed producer and distributor of medicinal cannabis and cannabis-derived products in Colombia. The company's website is https://www.blueberriesmed.com/.

Frequently asked questions about Blueberries Medical

5 analysts currently rate the Blueberries Medical stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Blueberries Medical share trades at 0.01 EUR (0.01 CAD).

The Blueberries Medical share (BBM.CN) is listed on 4 stock exchanges, including: Frankfurt (1OA.F), München (1OA.MU).

The revenue cannot currently be calculated for Blueberries Medical.

The profit cannot currently be calculated for Blueberries Medical.

The P/E ratio cannot be calculated for Blueberries Medical at the moment.

The P/S cannot be calculated for Blueberries Medical currently.

The Eulerpool Quality Score for Blueberries Medical is 4/10.

The ISIN of Blueberries Medical is CA09609Y1016. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Blueberries Medical is A2PD5T. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Blueberries Medical is BBM.CN. The ticker symbol is used to trade Blueberries Medical shares on the stock exchange.

Fair ValueTerminal
0.01 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Apr 9, 2014
ISIN
CA09609Y1016
Cusip
09609Y101
Market capitalization
5.99 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
18.64
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-518.68 %
Last updated Oct 19, 2026, 5:55 PM

Blueberries Medical Peer Group

Blueberries Medical Ticker

CNQ · BBM.CNFRANKFURT · 1OA.FMUNICH · 1OA.MUOTC · BBRRF

Blueberries Medical FIGI

BBM:CN · BBG0069HXDH6BBM:CF · BBG0069HXDQ6BBM:TG · BBG0069HXDZ6BBM:TW · BBG0069HXF18BBM:DG · BBG0069HXF72BBM:QF · BBG0086KMSZ7BBM:QH · BBG0086KMT03BBM:TO · BBG00G8YL1P8BBM:DL · BBG00K7X4Y60BBM:DM · BBG00K7XL5V6BBM:DN · BBG00K7Y0FD5BBM:QG · BBG00LN9MJ20